Skip to main content

Rutz Michael P's Form 4 filing

Sotera Health Co (SHC) · filed Aug 27, 2021

Accession no.
0001822479-21-000059
Filed
Aug 27, 2021
Trade date
Aug 25, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction. Open-market sales total $1.68M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rutz Michael PCIK 0001599220Officer (President of Sterigenics)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 25, 2021Common Stock, $0.01 par value per share ("Common Stock")SSaleDisposed−67,000$25.03F1−$1,677,010554,043Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted-average share price. The lowest price at which shares were sold was $24.90 and the highest price at which shares were sold was $25.39. The Reporting Person undertakes to provide, upon request of the SEC or a security holder of the issuer, complete information regarding the number of shares sold at each price.

Referenced by the price of 1 transaction in Table I.

Remarks

The Power of Attorney for Mr. Rutz is filed as an exhibit to the Form 3 filed on November 20, 2020, which is hereby incorporated by reference.

Read the full filing on SEC EDGAR (opens in a new tab)